{"href":"https://api.simplecast.com/oembed?url=https%3A%2F%2Ftoga-podcast.simplecast.com%2Fepisodes%2Fa-conversation-with-surein-arulananda-99E6D7Cn","width":444,"version":"1.0","type":"rich","title":"A/Prof Surein Arulananda: A Masterclass in Career Growth","thumbnail_width":300,"thumbnail_url":"https://image.simplecastcdn.com/images/37b381d6-a6e7-4025-a6ac-23a0ce7134b8/887cbec8-f725-42a2-938b-5785e4abc734/podcast_creative_interview_surein.jpg","thumbnail_height":300,"provider_url":"https://simplecast.com","provider_name":"Simplecast","html":"<iframe src=\"https://player.simplecast.com/b8e07aa5-9056-4d13-8bda-d40e65d82fef\" height=\"200\" width=\"100%\" title=\"A/Prof Surein Arulananda: A Masterclass in Career Growth\" frameborder=\"0\" scrolling=\"no\"></iframe>","height":200,"description":"In this episode of TOGA's 'Conversations in Lung Cancer Research,' A/Prof Mel Moore interviews A/Prof Surein Arulananda, the interim Director of Medical Oncology and Thoracic Oncology Trials Lead at Monash Health and Convenor at the 2026 TOGA ASM. They discuss his academic background, his unexpected journey into oncology, a fellowship in Boston and MBA in London and his vision for the future of lung cancer treatment."}